RT Book, Section A1 Hoffman, Robert S. A1 Howland, Mary Ann A1 Lewin, Neal A. A1 Nelson, Lewis S. A1 Goldfrank, Lewis R. SR Print(0) ID 1108439057 T1 Case Study 10 T2 Goldfrank's Toxicologic Emergencies, 10e YR 2015 FD 2015 PB McGraw-Hill Education PP New York, NY SN 9780071801843 LK accessemergencymedicine.mhmedical.com/content.aspx?aid=1108439057 RD 2024/03/28 AB HistoryA 32 year-old woman with no past medical history presented to the emergency department with a 2 day history of a painless, rapidly expanding lesion on her back. She first noticed the lesion 2 days prior but did not recall any trauma or other inciting factors. The woman denied headache, shortness of breath, chest pain, nausea, vomiting, diarrhea or dysuria, but she reported subjective fever and malaise for 2 days. She was not taking any medications, she drank alcohol socially, and she denied intravenous drug use. She worked as an accountant in New York City and traveled frequently to a vacation home in Montauk, Long Island.Immediate Assessment and ManagementOn presentation to the emergency department, the patient was well appearing and in no apparent distress. Vital signs were: blood pressure, 102/52 mm Hg; pulse, 92 beats/min; respiratory rate,16 breaths/min; tympanic temperature, 98.7°F (37.1°C); and oxygen saturation, 100% on room air. A complete physical examination was entirely within normal limits, except for her skin examination. This was notable for a solitary 9 cm annular plaque on the upper back with central hemorrhagic crust overlying a 5 cm violaceous plaque surrounded by a ring of erythema (Fig. CS10–1). The lesion was only mildly tender to palpation, and there was no underlying fluctuance.What Is the Differential Diagnosis?The only remarkable finding in this patient is the 2 day old skin lesion, associated with subjective fever and malaise. The differential diagnosis includes infectious diseases such as cellulitis or a bacterially superinfected cyst or arthropod bite, sporotrichosis, lyme disease, and anthrax (Chap. 133); drug reactions such as a fixed-drug eruption, or given the necrotic appearance of the lesion, necrosis due to warfarin or heparin therapy (Chaps. 18 and 60); and necrotic spider bites (Chap. 118).Immediate Assessment and ManagementA more detailed history failed to reveal any clues. The woman specifically denied knowledge of tick or spider bites, and she neither worked, lived, nor vacationed in an area known to be inhabited by brown recluse spiders. However, she frequented an area of Long Island where ticks are endemic. An intravenous line was inserted and a complete blood count, basic metabolic panel, and liver function tests were sent; all were within normal limits. The patient was started on vancomycin to provide Staphylococcus aureus and methicillin-resistant S. aureus coverage for a presumed bacterial infection or necrotizing soft tissue infection.Cases such as these require an immediate assessment for potential public health implications. Once a diagnosis of cutaneous anthrax is considered, the possibility of malicious exposure mandates a coordinated effort to establish a definitive diagnosis. It is important to recall that one of the cases of cutaneous anthrax that occurred following the malicious letters in New York in 2001 involved the case of a small child who was initially diagnosed with brown recluse spider envenomation. Additionally, while spider envenomation may occur outside of regions considered to be endemic as movement of spiders in suitcases, packages, or vehicles may occasionally occur, a new pattern of envenomation may represent a local infestation or the expansion of an ...